How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
Amid tariff wars, Canada’s pharma services industry sees opportunity
 Key Insights Canadian firms are positioning the country as a hub for pharmaceutical services Some industry insiders…
Breakthrough blood pressure drug could be on NHS next year
A new daily pill for high blood pressure is set to revolutionise treatment for the first time in…
IL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk
GBD Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204…
Join Sept. 18 with George Church and this year’s top biotech startups
I asked AI the othÂer day how many biotechs have been co-foundÂed by HarÂvard’s George Church. About 50…
Where Are All the AI Drugs?
A new drug usually starts with a tragedy. Peter Ray knows that. Born in what is now Zimbabwe,…
First New PTSD Drug in Two Decades On the Horizon?
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…